Exelixis Clinical Site #2 — Omaha, Nebraska

Exelixis Clinical Site #2 is a clinical research site located in Omaha, Nebraska, United States 68130.

Crixeo Health Trust Score: 61/100 (FAIR). This profile has not yet been claimed by the site owner.

Exelixis Clinical Site #2 has participated in 2 clinical trials with 2 currently active.

Therapeutic areas: Renal Cell Carcinoma, Renal Cell Carcinoma (RCC), Metastatic Castration-Resistant Prostate Cancer (mCRPC).

Sponsors: Exelixis.

Sponsor Feasibility Report

Trust Score: 61/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Exelixis Clinical Site #2?

Exelixis Clinical Site #2 has a Crixeo Trust Score of 61/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Exelixis Clinical Site #2 conducted?

Exelixis Clinical Site #2 has 2 clinical trials on record, with 2 currently active. Their work covers Renal Cell Carcinoma, Renal Cell Carcinoma (RCC), Metastatic Castration-Resistant Prostate Cancer (mCRPC).

Is Exelixis Clinical Site #2 accredited by Crixeo Health?

Exelixis Clinical Site #2 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Exelixis Clinical Site #2?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.